Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
Methods in Molecular Medicine|November 7, 2007
Murine antigen-induced arthritisWim B van den Berg, Leo A B Joosten, Peter L E M van Lent
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 27, 2013
The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disordersDebbie M Roeleveld, Annemarie E M van Nieuwenhuijze, Wim B van den Berg, et al.
Biomaterials|December 31, 2003
Role of gene therapy in tissue engineering procedures in rheumatology: the use of animal modelsPeter M van der Kraan, Fons A J van de Loo, Wim B van den Berg
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 26, 2003
Large scale protein production of the extracellular domain of the transforming growth factor-beta type II receptor using the Pichia pastoris expression systemAlwin Scharstuhl, Harrie Glansbeek, Elly L Vitters, et al.
Cytokine|August 11, 2012
Interleukin-32: a predominantly intracellular proinflammatory mediator that controls cell activation and cell deathBas Heinhuis, Mihai G Netea, Wim B van den Berg, et al.
Arthritis and Rheumatism|June 10, 2004
Increased synovial tissue NF-kappa B1 expression at sites adjacent to the cartilage-pannus junction in rheumatoid arthritisMaria J Benito, Eithne Murphy, Evelyn P Murphy, et al.
Arthritis Research & Therapy|April 6, 2006
TGF beta-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad7Esmeralda N Blaney Davidson, Elly L Vitters, Wim B van den Berg, et al.
Current Drug Targets|March 5, 2010
To seek shelter from the WNT in osteoarthritis? WNT-signaling as a target for osteoarthritis therapyArjen B Blom, Peter L van Lent, Peter M van der Kraan, et al.
Plos One|October 24, 2014
Fc gamma receptor IIb on GM-CSF macrophages controls immune complex mediated inhibition of inflammatory signalsKim C M Santegoets, Mark H Wenink, Wim B van den Berg, et al.
Pageof 18